Frequency and significance of the novel single nucleotide missense polymorphism Val109Asp in the human gene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseases

Cardiovascular Diabetology

Volumn 6, Issue , 2007, Pages

  Schäffler, Andreas ^a   Zeitoun, Martina ^a   Wobser, Hella ^a   Buechler, Christa ^a   Aslanidis, Charalampos ^a   Herfarth, Hans ^b  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ASPARTIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DNA FRAGMENT; FIBRIC ACID DERIVATIVE; FIBRINOGEN; GLITAZONE DERIVATIVE; HISTIDINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; INSULIN; METFORMIN; OMENTIN; STEROID; SULFONYLUREA; UNCLASSIFIED DRUG; VALINE; CYTOKINE; ITLN1 PROTEIN, HUMAN; LECTIN;

ADULT; AMINO ACID SEQUENCE; ANTHROPOMETRY; ARTICLE; CAUCASIAN; CHIMPANZEE; CHRONIC DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DIET THERAPY; ENTERITIS; EXON; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC CONSERVATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; AMINO ACID SUBSTITUTION; GENETICS; REFERENCE VALUE;

AMINO ACID SUBSTITUTION; ASPARTIC ACID; CHRONIC DISEASE; COHORT STUDIES; CYTOKINES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; HUMANS; INFLAMMATORY BOWEL DISEASES; LECTINS; MALE; MUTATION, MISSENSE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES; VALINE;

EID: 33847676743     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-6-3     Document Type: Article

References (22)

1. Koerner A Kratzsch, J, Kiess, W. Adipocytokines: Leptin--the classical, resistin--the controversial, adiponectin - the promising, and more to come Best Pract Res Clin Endocrinol Metab 2005 19 525-546 10.1016/ j.beem.2005.07.008 16311215
2. Yang RZ Shuldiner, A.R., Gong, D.W. Cloning of omentin, a new adipokine from human omental fat tissue. Unpublished. NCBI nucleotide database 2003 accession number: AY549722
3. Yang R Xu, A., Pray, J., Hu, H., Jadhao, S., Hansen, B., Shuldiner, A., Mc-Lenithan, J., Gong, D. Cloning of omentin, a new adipocytokine from omental fat tissue in humans. Diabetes 2003 Suppl. 1 1-OR A1
4. Schaffler A Neumeier M Herfarth H Furst A Scholmerich J Buchler C Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue Biochim Biophys Acta 2005 1732 1-3 96-102 16386808
5. Tsuji S Uehori J Matsumoto M Suzuki Y Matsuhisa A Toyoshima K Seya T Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall J Biol Chem 2001 276 26 23456-23463 10.1074/jbc.M103162200 11313366
6. Yang RZ Lee MJ Hu H Pray J Wu HB Hansen BC Shuldiner AR Fried SK McLenithan JC Gong DW Identification of omentin as a novel depot-specific adipokine in human adipose tissue: Possible role in modulating insulin action Am J Physiol Endocrinol Metab 2006 290 6 E1253-61 10.1152/ajpendo.00572.2004 16531507
7. Schäffler A Schölmerich, J, Büchler, C Mechanisms of disease: Adipocytokines and visceral adipose tissue - emerging role in intestinal and mesenteric diseases. Nature Clinical Practice (Gastroenterology and Hepatology) 2005 2 2 103-111 10.1038/ncpgasthep0090
8. Schäffler A Herfarth, H Creeping fat in Crohn's disease: Travelling in a creeper lane of research? Gut 2005 54 742-744 10.1136/ gut.2004.061531 15888774
9. Peyrin-Biroulet L Chamaillard M Gonzalez F Beclin E Decourcelle C Antunes L Gay J Neut C Colombel JF Desreumaux P Mesenteric fat in Crohn's disease: A pathogenetic hallmark or an innocent bystander? Gut 2006
10. Schaffler A Fürst, A., Büchler, C., Paul, G, Rogler, G., Schölmerich, J., Herfarth, H. Secretion of RANTES (CCL5) and IL-10 from mesenteric adipose tissue and from creeping fat in Crohn's disease: regulation by steroid treatment. Journal of Gastroenterology and Hepatology 2005 in press
11. Schaffler A Fürst, A., Büchler, C., Paul, G, Rogler, G., Schölmerich, J., Herfarth, H. VEGF secretion from mesenteric adipose tissue and from creeping fat in Crohn's disease. Journal of Gastroenterology and Hepatology 2005 in press
12. Paul G Schaffler A Neumeier M Furst A Bataillle F Buechler C Muller-Ladner U Scholmerich J Rogler G Herfarth H Profiling adipocytokine secretion from creeping fat in Crohn's disease Inflamm Bowel Dis 2006 12 6 471-477 10.1097/00054725-200606000-00005 16775490
13. Karmiris K Koutroubakis IE Xidakis C Polychronaki M Voudouri T Kouroumalis EA Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease Inflamm Bowel Dis 2006 12 2 100-105 10.1097/01.MIB.0000200345.38837.46 16432373
14. Karmiris K Koutroubakis IE Kouroumalis EA The emerging role of adipocytokines as inflammatory mediators in inflammatory bowel disease Inflamm Bowel Dis 2005 11 9 847-855 10.1097/01.mib.0000178915.54264.8f 16116320
15. Schaffler A Furst A Buchler C Paul G Rogler G Scholmerich J Herfarth H Vascular endothelial growth factor secretion from mesenteric adipose tissue and from creeping fat in Crohn's disease J Gastroenterol Hepatol 2006 21 9 1419-1423 16911686
16. Colombel JF Solem CA Sandborn WJ Booya F Loftus EV Jr. Harmsen WS Zinsmeister AR Bodily KD Fletcher JG Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: Correlation with endoscopic severity and C reactive protein Gut 2006 55 11 1561-1567 10.1136/gut.2005.084301 16648154
17. Matsuzawa Y The metabolic syndrome and adipocytokines FEBS Lett 2006 580 12 2917-2921 10.1016/j.febslet.2006.04.028 16674947
18. Singh B Mallika V Goswami B Metabolic syndrome: Diagnosis, potential markers and management-an update Clin Chim Acta 2006
19. Kralisch S Klein J Bluher M Paschke R Stumvoll M Fasshauer M Therapeutic perspectives of adipocytokines Expert Opin Pharmacother 2005 6 6 863-872 10.1517/14656566.6.6.863 15952917
20. Rajala MW Obici S Scherer PE Rossetti L Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production J Clin Invest 2003 111 2 225-230 151868 12531878 10.1172/JCI200316521
21. Okamoto Y Kihara S Funahashi T Matsuzawa Y Libby P Adiponectin: A key adipocytokine in metabolic syndrome Clin Sci (Lond) 2006 110 3 267-278 16464169
22. Gasche C Scholmerich J Brynskov J D'Haens G Hanauer SB Irvine EJ Jewell DP Rachmilewitz D Sachar DB Sandborn WJ Sutherland LR A simple classification of Crohn's disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998 Inflamm Bowel Dis 2000 6 1 8-15 10701144